Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serotonergic system, cognition, and BPSD in Alzheimer’s disease
Saikat Chakraborty, Jack C. Lennon, Sridhar A. Malkaram, et al.
Neuroscience Letters (2019) Vol. 704, pp. 36-44
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation
Jack C. Lennon, Stephen L. Aita, Victor A. Del Bene, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 8, pp. 1461-1471
Open Access | Times Cited: 121
Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD?
Nermin Eissa, Adel Sadeq, Astrid Sasse, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 76
The role of serotonin in declarative memory: A systematic review of animal and human research
Rebecca C. Coray, Boris B. Quednow
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104729-104729
Open Access | Times Cited: 54
Distinguishing features of depression in dementia from primary psychiatric disease
Daniel Fisher, Jeffrey T. Dunn, Hongxin Dong
Discover Mental Health (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Single-cell spatial transcriptomics reveals distinct patterns of dysregulation in non-neuronal and neuronal cells induced by the Trem2R47H Alzheimer’s risk gene mutation
Kevin G. Johnston, Bereket T Berackey, Kristine M. Tran, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 9
Comparisons of neuroinflammation, microglial activation, and degeneration of the locus coeruleus-norepinephrine system in APP/PS1 and aging mice
Song Cao, Daniel Fisher, Guadalupe Rodríguez, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 51
Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics
Valeria Calsolaro, Grazia Daniela Femminella, Sara Rogani, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 246-246
Open Access | Times Cited: 47
Behavioral and Psychological Symptoms of Dementia as a Means of Communication: Considerations for Reducing Stigma and Promoting Person-Centered Care
Alison Warren
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 28
Cornuside ameliorates cognitive impairments in scopolamine induced AD mice: Involvement of neurotransmitter and oxidative stress
Zexing Wang, Wenwen Lian, Jun He, et al.
Journal of Ethnopharmacology (2022) Vol. 293, pp. 115252-115252
Closed Access | Times Cited: 28
Neurochemical organization of cortical proteinopathy and neurophysiology along the Alzheimer's disease continuum
Alex I. Wiesman, Jonathan Gallego‐Rudolf, Sylvia Villeneuve, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 6316-6331
Open Access | Times Cited: 6
Psychedelic‐inspired approaches for treating neurodegenerative disorders
Hannah N. Saeger, David E. Olson
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 109-127
Open Access | Times Cited: 33
Emotion Processing Dysfunction in Alzheimer’s Disease: An Overview of Behavioral Findings, Systems Neural Correlates, and Underlying Neural Biology
Shefali Chaudhary, Simon Zhornitsky, Herta H. Chao, et al.
American Journal of Alzheimer s Disease & Other Dementias® (2022) Vol. 37
Open Access | Times Cited: 25
Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms
Shalini Saggu, Ava Bai, Mae Aida, et al.
GeroScience (2024)
Open Access | Times Cited: 5
Treadmill exercise ameliorates chronic REM sleep deprivation-induced anxiety-like behavior and cognitive impairment in C57BL/6J mice
Feng Tai, Wang Che, Xin Deng, et al.
Brain Research Bulletin (2020) Vol. 164, pp. 198-207
Closed Access | Times Cited: 39
5-Hydroxytryptophan: A precursor of serotonin influences regional blood-brain barrier breakdown, cerebral blood flow, brain edema formation, and neuropathology
Aruna Sharma, Mark A. Smith, Dafin F. Mureşanu, et al.
International review of neurobiology (2019), pp. 1-44
Closed Access | Times Cited: 38
Kaixinsan, a Well-Known Chinese Herbal Prescription, for Alzheimer's Disease and Depression: A Preclinical Systematic Review
Huan Fu, Zhen Xu, Xile Zhang, et al.
Frontiers in Neuroscience (2020) Vol. 13
Open Access | Times Cited: 38
Potential Pathways for Circadian Dysfunction and Sundowning-Related Behavioral Aggression in Alzheimer’s Disease and Related Dementias
William D. Todd
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 33
Emphasizing the Crosstalk Between Inflammatory and Neural Signaling in Post-traumatic Stress Disorder (PTSD)
Anusha Govindula, Niraja Ranadive, Madhavan Nampoothiri, et al.
Journal of Neuroimmune Pharmacology (2023) Vol. 18, Iss. 3, pp. 248-266
Open Access | Times Cited: 12
Serotonergic dysfunction may mediate the relationship between alcohol consumption and Alzheimer’s disease
Samantha Pierson, Louis J. Kolling, Thomas D. James, et al.
Pharmacological Research (2024) Vol. 203, pp. 107171-107171
Open Access | Times Cited: 4
Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment
Paloma Mayo, Jorge Pascual-Guerra, Enrique Crisman, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2367-2419
Open Access | Times Cited: 4
Taurine protection attenuates bisphenol-A-induced behavioral, neurochemical, and histopathological alterations in male rats
Mohamed Nazmy, Neveen A. Noor, Faten F. Mohammed, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Deciphering the Functions of Raphe–Hippocampal Serotonergic and Glutamatergic Circuits and their Deficits in Alzheimer’s Disease
Wanting Yu, R Zhang, Aosheng Zhang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1234-1234
Open Access
Investigating the neuroprotective effects of Dracocephalum moldavica extract and its effect on metabolomic profile of rat model of sporadic Alzheimer's disease
Marjan Talebi, Seyed Abdulmajid Ayatollahi, Mohammad Ali As’habi, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e42412-e42412
Open Access
Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
Dubravka Švob Štrac, Marcela Konjevod, Marina Šagud, et al.
Pharmacogenomics and Personalized Medicine (2021) Vol. Volume 14, pp. 631-653
Open Access | Times Cited: 26
5-HT7 receptors in Alzheimer's disease
Maite Solas, Debby Van Dam, Jana Janssens, et al.
Neurochemistry International (2021) Vol. 150, pp. 105185-105185
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top